Cargando…

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis

BACKGROUND: CLEC5A is a member of the C-type lectin superfamily. It can activate macrophages and lead to a series of immune-inflammation reactions. Previous studies reveal the role of CLEC5A in infection and inflammation diseases. METHOD: We acquire and analyze data from The Cancer Genome Atlas (TCG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Rui, Wu, Wantao, Chen, Si-Yu, Liu, Zheng-Zheng, Wen, Zhi-Peng, Yu, Jing, Zhang, Long-Bo, Liu, Zaoqu, Zhang, Jian, Luo, Peng, Zeng, Wen-Jing, Cheng, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376251/ https://www.ncbi.nlm.nih.gov/pubmed/35979347 http://dx.doi.org/10.3389/fimmu.2022.831542

Ejemplares similares

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
por: Zhang, Jingwei, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

A Novel Thrombosis-Related Signature for Predicting Survival and Drug Compounds in Glioblastoma
por: Zeng, Wen-Jing, et al.
Publicado: (2022)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis
por: Li, Xin-yu, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma
por: Guo, Rui-Ming, et al.
Publicado: (2018)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
por: Zhang, Hao, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer
por: Lin, Anqi, et al.
Publicado: (2023)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity
por: Liu, Ting, et al.
Publicado: (2023)

Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance
por: Zheng, Kun, et al.
Publicado: (2023)

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
por: Yin, Chengliang, et al.
Publicado: (2021)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
por: Zhang, Yanqiu, et al.
Publicado: (2023)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
por: Yan, Zhongyi, et al.
Publicado: (2016)

Pan-immune-inflammation value is associated with the clinical stage of colorectal cancer
por: Zhao, HanZheng, et al.
Publicado: (2022)

JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer
por: Liang, Xisong, et al.
Publicado: (2022)

CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer
por: Li, DaPeng, et al.
Publicado: (2019)

CLEC5A is a critical receptor in innate immunity against Listeria infection
por: Chen, Szu-Ting, et al.
Publicado: (2017)

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors
por: Zeng, Yu, et al.
Publicado: (2021)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment
por: Gong, Xun, et al.
Publicado: (2023)

Pan-cancer analysis of clinical significance and associated molecular features of glycolysis
por: Liu, Yi-chen, et al.
Publicado: (2021)

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients
por: Tan, Li-Ming, et al.
Publicado: (2019)

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
por: Tu, Zewei, et al.
Publicado: (2022)

Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis
por: Chang, Yao-Wen, et al.
Publicado: (2015)

Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Zheng, Haosheng, et al.
Publicado: (2022)

CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
por: Sung, Pei-Shan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qnpbjbhc6apuf8bn4l6681nd6l